Literature DB >> 184802

Clearing factor lipase (lipoprotein lipase) activator. A method for the measurement of the net activating ability of human sera.

M P Rogers, D Barnett, D S Robinson.   

Abstract

The hydrolysis of an emulsified triglyceride substrate by clearing factor lipase (lipoprotein lipase) normally requires the presence of particular activating polypeptide species. These are present in serum, together with other inhibitory species, as part of the serum lipoproteins. The paper describes a method whereby the net activating ability of individual human sera may be measured routinely. In a normal population, this activating ability is shown to be correlated positively with the fasting serum triglyceride concentration. As the fasting triglyceride concentration increases, there is a rise in the proportion of the total activating ability that is associated with the very low density lipoproteins. A dietary fat load does not raise the total activating ability but does increase the proportion of the total that is associated with the serum lipoproteins of lowest density.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184802     DOI: 10.1016/0021-9150(76)90147-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Action of liproprotein lipase on apoprotein-depleted chylomicrons.

Authors:  T W Lukens; J Borensztajn
Journal:  Biochem J       Date:  1978-10-01       Impact factor: 3.857

2.  Hydrolysis of chylomicron triacylglycerol by endothelium-bound lipoprotein lipase. Effect of decreased apoprotein C-II/C-III ratio.

Authors:  T J Kotlar; J Borensztajn
Journal:  Biochem J       Date:  1979-10-01       Impact factor: 3.857

3.  The effect in vitro of high-density lipoprotein on hydrolysis of triacylglycerol by lipoprotein lipase.

Authors:  M P Rogers; I Hutchinson
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

4.  Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase.

Authors:  T W Lukens; J Borensztajn
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

5.  Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.

Authors:  M L Kashyap; L S Srivastava; C Y Chen; C G Perisutti; M Campbell; R F Lutmer; C J Glueck
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.